Red Sun speeds up cooperation with biological enterprise to develop paraquat antidote
Date:03-27-2020
On March 24,
Nanjing Red Sun announced a plan to raise a capital of Yuan26.39 million to control Hainan Kunning Biotechnology Ltd. With this, the registered capital of Kunning Biotechnology will increase to Yuan30.3 million yuan, of which Red Sun holds Yuan20.3 million, accounting for 67% of the registered capital.
The Institute of Environmental and Plant Protection of the Chinese Academy of Tropical Agricultural Sciences, together with experts from the First Affiliated Hospital of Hainan Medical College, have succeeded in developing the world's first new compound, a paraquat-specific antidote, which has been granted a national invention patent and the right of claim. Hainan Kunning Biotechnology is a professional high-tech company specialized in the development of specific antidotes for pyridine herbicides such as paraquat, covering research optimization, animal experimentation, clinical trials and industrialization. The company has signed worldwide exclusive transfer agreements with research institutions over the development, production and operation of the paraquat-specific antidote patent/subsequent patents-related products. So far, preliminary and pilot trials have been completed, which will allow for the industrialization after obtaining the clinical trial and registration approvals from the National Medical Products Administration.
At present, the safety and effectiveness of the paraquat antidote has been proven after being experimented on animals. This is the first time that mankind can fund a small molecular compound which can specifically combine the paraquat molecule to quickly make it lose toxicity, a remarkable achievement in the detoxification of the pyridine herbicide.
Red Sun has been dedicated to the research and industrialization of the green pyridine pesticide series over the last 20 years, having successfully created its pyridine base industry chain with the principles of being "world leading, independent and controllable, largest scale, energy saving and environment friendly". Paraquat is one of the main products of its industrial chain, based on which, the company’s core competence in the industrial chain, brand image and product quality has enabled the company’s business to expand across a large number of countries and regions around the world.
To this end, Red Sun and Kunning Biotechnology have allied for the purpose of the joint development of the paraquat specific antidote, which is a clinical first-aid medicine to treat poisonous elements, thus putting an end to the history of the non-existence of pyridine herbicide antidotes in the past 60 years and safeguarding the pyridine herbicide industry.